NFKB1 and neoplasm: The role of miR-31 is dual: it acts as an oncogene and a tumor suppressor according to the cellular context, and its expression is increased in PDAC, where it is associated with tumor growth, inflammation, and therapy resistance, including through the modulation of NF-κB signaling.